Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes

被引:0
|
作者
Blicklé, JF [1 ]
Sapin, R
Andrès, E
机构
[1] Hop Civil, Clin Med B, Serv Med Interne B, F-67091 Strasbourg, France
[2] Fac Med Strasbourg, Lab Univ Biophys, Unite Anal Endocriniennes, F-67085 Strasbourg, France
来源
DIABETES & METABOLISM | 2000年 / 26卷 / 04期
关键词
specific insulin; total proinsulin; intact proinsulin; impaired glucose tolerance; obesity; diabetes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent development of specific radioimmunoassays of insulin (Ins) and proinsulin (PI) led some authors to question the classical data on insulinosecretion in patients with abnormal glucose tolerance. The aim of this work was to determine the participation of intact proinsulin (iPI) and its split fragments to total insulinsecretion in obese subjects and in various stages of glucose intolerance determined by an oral glucose load according to the WHO recommendations. Five groups were constituted: non obese controls (C), obese subjects with normal glucose tolerance (O), non obese subjects with impaired glucose tolerance (I), obese subjects with impaired glucose tolerance (OI) and diabetic patients (O). The basal level of total Proinsulin (tPI) of D and OI was significantly higher than that of C, but the tPI/Ins ratio did not differ between the five groups. After glucose load, this ratio tended to be higher in D, but not significantly. No statistical difference between groups was observed for the iPI/Ins ratio. These results indicate that the determination of tPI is at least as informative or more than that of iPI. Furthermore, the proportionally constant participation of PI to insulin secretion observed in various stages of glucose intolerance suggests that the results obtained in the past with non specific insulin radioimmunoassays remain valid.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 50 条
  • [1] Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes
    Mäkimattila, S
    Fineman, MS
    Yki-Järvinen, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2822 - 2827
  • [2] Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
    Hermans, MP
    Levy, J
    Coppack, S
    Turner, RC
    DIABETOLOGIA, 1996, 39 : 605 - 605
  • [3] Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Pixner, Thomas
    Chaikouskaya, Tatsiana
    Lauth, Wanda
    Zimmermann, Georg
    Moerwald, Katharina
    Lischka, Julia
    Furthner, Dieter
    Awender, Elisabeth
    Geiersberger, Sabine
    Maruszczak, Katharina
    Forslund, Anders
    Anderwald, Christian-Heinz
    Cadamuro, Janne
    Weghuber, Daniel
    Bergsten, Peter
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [4] Skin capillary density in subjects with impaired glucose tolerance and patients with Type 2 diabetes
    Jaap, AJ
    Shore, AC
    Stockman, AJ
    Tooke, JE
    DIABETIC MEDICINE, 1996, 13 (02) : 160 - 164
  • [5] Antihypertensive drugs as predictors of Type 2 diabetes among subjects with impaired glucose tolerance
    Rajala, U
    Qiao, Q
    Laakso, M
    Keinänen-Kiukaanniemi, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (03) : 231 - 239
  • [6] CLA supplementation in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
    Mahon, AK
    Shi, L
    Belury, MA
    FASEB JOURNAL, 2000, 14 (04): : A736 - A736
  • [7] Pulsatile insulin secretion in type 2 diabetes, impaired glucose tolerance and healthy subjects
    Ritzel, R
    Schulte, M
    Porksen, N
    Juhl, CB
    Schmitz, O
    Schmiegel, WH
    Nauck, MA
    DIABETES, 2000, 49 : A253 - A253
  • [8] Effects of a non-glucose food preload on oral glucose tolerance in subjects with impaired glucose tolerance and type 2 diabetes
    Trico, D.
    Tulipani, A.
    Baldi, S.
    Morgantini, C.
    Macedo, M. P.
    Mari, A.
    Ferrannini, E.
    Natali, A.
    DIABETOLOGIA, 2014, 57 : S220 - S220
  • [9] Prevalence of impaired fasting glucose, impaired glucose tolerance and newly-diagnosed diabetes in subjects at risk of developing type 2 diabetes
    Tankova, T.
    Chakarova, N.
    Lazarova, M.
    Atanassova, I.
    DIABETOLOGIA, 2007, 50 : S163 - S163
  • [10] Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
    Delorme, S
    Chiasson, JL
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 184 - 189